기술 _ 시장 자료 Cancer Biomarkers Market by Type ( Protein Biomarker , Genetic Biomarker ) , Cancer Type ( Breast , Melanoma , Leukemia , Lung ) , Profiling Technology ( Omics , Imaging , Immunoassay , Bioinformatics ) , Application ( Diagnosis , Prognostics , R & D ) - Global Forecast to 2022 
 전 세계 암 바이오 마커 시장 2022 
 ◇ 발행처 : MNM ◇ 발행일 : 2019 년 10 월 ◇ 가격 : $ 7 , 150 [ PDF ] ◇ 페이 지수 : 267 쪽 
 4 . 2 Asia Pacific Market , By Profiling Technology and Application 
 4 . 3 Cancer Biomarkers Market Share , By Cancer Type , 2017 vs 2022 
 4 . 4 Global Market for Cancer Biomarkers : Share , By Biomarker Type , 2015 to 2022 
 6 Cancer Biomarkers Market , By Biomarker Type ( Page No . - 48 ) 
 7 Market , By Cancer Type ( Page No . - 63 ) 
 8 Market , By Profiling Technology ( Page No . - 89 ) 
 9 Cancer Biomarkers Market , By Application ( Page No . - 133 ) 
 10 Market , By Region ( Page No . - 146 ) 
 11 Competitive Landscape ( Page No . - 208 ) 
 12 Company Profiles ( Page No . - 209 ) 
 13 Appendix ( Page No . - 257 ) 
 List of Tables ( 268 Tables ) 
 Table 2 Global Protein Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 3 North America : Protein Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 4 Europe : Protein Market , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 5 Asia Pacific : Protein Market , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 6 Global Genetic Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 7 North America : Genetic Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 9 Asia Pacific : Genetic Market , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 10 Global Other Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 11 North America : Other Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 12 Europe : Other Market , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 13 Asia Pacific : Other Market , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 15 Global Breast Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 16 North America : Breast Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 17 Europe : Breast Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 18 Asia Pacific : Breast Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 19 Global Lung Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 20 North America : Lung Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 21 Europe : Lung Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 22 Asia Pacific : Lung Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 23 Global Colorectal Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 25 Europe : Colorectal Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 26 Asia Pacific : Colorectal Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 27 Global Prostate Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 28 North America : Prostate Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 29 Europe : Prostate Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 30 Asia Pacific : Prostate Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 44 North America : Thyroid Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 45 Europe : Thyroid Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 46 Asia Pacific : Thyroid Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 47 Global Bladder Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 48 North America : Bladder Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 49 Europe : Bladder Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 50 Asia Pacific : Bladder Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 51 Global Kidney Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 52 North America : Kidney Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 53 Europe : Kidney Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 54 Asia Pacific : Kidney Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 55 Global Other Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 56 North America : Other Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 58 Asia Pacific : Other Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 59 Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 60 Market for Omics Technologies , By Type , 2015 – 2022 ( USD Million ) 
 Table 61 Market for Omics Technologies , By Region , 2015 – 2022 ( USD Million ) 
 Table 62 North America : Market for Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 63 Europe : Market for Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 64 Asia Pacific : Market for Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 65 Market for Proteomics , By Region , 2015 – 2022 ( USD Million ) 
 Table 66 North America : Market for Proteomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 67 Europe : Market for Proteomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 68 Asia Pacific : Market for Proteomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 69 Market for Genomics , By Type , 2015 – 2022 ( USD Million ) 
 Table 70 Market for Genomics , By Region , 2015 – 2022 ( USD Million ) 
 Table 71 North America : Market for Genomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 72 Europe : Market for Genomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 73 Asia Pacific : Market for Genomics , By Country , 2015 – 2022 ( USD Million ) 
 Table 74 Market for NGS , By Region , 2015 – 2022 ( USD Million ) 
 Table 75 North America : Market for NGS , By Country , 2015 – 2022 ( USD Million ) 
 Table 76 Europe : Market for NGS , By Country , 2015 – 2022 ( USD Million ) 
 Table 77 Asia Pacific : Market for NGS , By Country , 2015 – 2022 ( USD Million ) 
 Table 79 North America : Market for PCR , By Country , 2015 – 2022 ( USD Million ) 
 Table 80 Europe : Market for PCR , By Country , 2015 – 2022 ( USD Million ) 
 Table 81 Asia Pacific : Market for PCR , By Country , 2015 – 2022 ( USD Million ) 
 Table 82 Market for Other Omics Technologies , By Region , 2015 – 2022 ( USD Million ) 
 Table 83 North America : Market for Other Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 84 Europe : Market for Other Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 85 Asia Pacific : Market for Other Omics Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 86 Market for Imaging Technologies , By Type , 2015 – 2022 ( USD Million ) 
 Table 87 Market for Imaging Technologies , By Region , 2015 – 2022 ( USD Million ) 
 Table 88 North America : Market for Imaging Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 89 Europe : Market for Imaging Technologies , By Country / Region , 2015 – 2022 ( USD Million ) 
 Table 90 Asia Pacific : Market for Imaging Technologies , By Country , 2015 – 2022 ( USD Million ) 
 Table 91 Market for Ultrasound , By Region , 2015 – 2022 ( USD Million ) 
 Table 92 North America : Market for Ultrasound , By Country , 2015 – 2022 ( USD Million ) 
 Table 93 Europe : Market for Ultrasound , By Country , 2015 – 2022 ( USD Million ) 
 Table 94 Asia Pacific : Market for Ultrasound , By Country , 2015 – 2022 ( USD Million ) 
 Table 95 Market for Ct , By Region , 2015 – 2022 ( USD Million ) 
 Table 96 North America : Market for Ct , By Country , 2015 – 2022 ( USD Million ) 
 Table 97 Europe : Market for Ct , By Country , 2015 – 2022 ( USD Million ) 
 Table 98 Asia Pacific : Market for Ct , By Country , 2015 – 2022 ( USD Million ) 
 Table 100 North America : Market for Mri , By Country , 2015 – 2022 ( USD Million ) 
 Table 101 Europe : Market for Mri , By Country , 2015 – 2022 ( USD Million ) 
 Table 102 Asia Pacific : Market for Mri , By Country , 2015 – 2022 ( USD Million ) 
 Table 103 Market for Pet , By Region , 2015 – 2022 ( USD Million ) 
 Table 104 North America : Market for Pet , By Country , 2015 – 2022 ( USD Million ) 
 Table 105 Europe : Market for Pet , By Country , 2015 – 2022 ( USD Million ) 
 Table 106 Asia Pacific : Market for Pet , By Country , 2015 – 2022 ( USD Million ) 
 Table 107 Market for Mammography , By Region , 2015 – 2022 ( USD Million ) 
 Table 108 North America : Market for Mammography , By Country , 2015 – 2022 ( USD Million ) 
 Table 109 Europe : Market for Mammography , By Country , 2015 – 2022 ( USD Million ) 
 Table 110 Asia Pacific : Market for Mammography , By Country , 2015 – 2022 ( USD Million ) 
 Table 112 North America : Market for Immunoassays , By Country , 2015 – 2022 ( USD Million ) 
 Table 113 Europe : Market for Immunoassays , By Country , 2015 – 2022 ( USD Million ) 
 Table 114 Asia Pacific : Market for Immunoassays , By Country , 2015 – 2022 ( USD Million ) 
 Table 115 Market for Cytogenetics , By Region , 2015 – 2022 ( USD Million ) 
 Table 116 North America : Market for Cytogenetics , By Country , 2015 – 2022 ( USD Million ) 
 Table 117 Europe : Market for Cytogenetics , By Country , 2015 – 2022 ( USD Million ) 
 Table 118 Asia Pacific : Market for Cytogenetics , By Country , 2015 – 2022 ( USD Million ) 
 Table 119 Market for Ish , By Region , 2015 – 2022 ( USD Million ) 
 Table 120 North America : Market for Ish , By Country , 2015 – 2022 ( USD Million ) 
 Table 121 Europe : Market for Ish , By Country , 2015 – 2022 ( USD Million ) 
 Table 122 Asia Pacific : Market for Ish , By Country , 2015 – 2022 ( USD Million ) 
 Table 123 Market for Other Cytogenetics - Based Tests , By Region , 2015 – 2022 ( USD Million ) 
 Table 124 North America : Market for Other Cytogenetics - Based Tests , By Country , 2015 – 2022 ( USD Million ) 
 Table 125 Europe : Market for Other Cytogenetics - Based Tests , By Country , 2015 – 2022 ( USD Million ) 
 Table 126 Asia Pacific : Market for Other Cytogenetics - Based Tests , By Country , 2015 – 2022 ( USD Million ) 
 Table 127 Global Market for Bioinformatics , By Region , 2015 – 2022 ( USD Million ) 
 Table 128 North America : Market for Bioinformatics , By Country , 2015 – 2022 ( USD Million ) 
 Table 129 Europe : Market for Bioinformatics , By Country , 2015 – 2022 ( USD Million ) 
 Table 130 Asia Pacific : Market for Bioinformatics , By Country , 2015 – 2022 ( USD Million ) 
 Table 132 Global Market for Diagnostics , By Region , 2015 – 2022 ( USD Million ) 
 Table 133 North America : Market for Diagnostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 134 Europe : Market for Diagnostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 135 Asia Pacific : Market for Diagnostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 136 Global Market for Research and Development , By Region , 2015 – 2022 ( USD Million ) 
 Table 137 North America : Market for Research and Development , By Country , 2015 – 2022 ( USD Million ) 
 Table 138 Europe : Market for Research and Development , By Country , 2015 – 2022 ( USD Million ) 
 Table 139 Asia Pacific : Market for Research and Development , By Country , 2015 – 2022 ( USD Million ) 
 Table 140 Global Market for Prognostics , By Region , 2015 – 2022 ( USD Million ) 
 Table 141 North America : Market for Prognostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 142 Europe : Market for Prognostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 143 Asia Pacific : Market for Prognostics , By Country , 2015 – 2022 ( USD Million ) 
 Table 145 North America : Market for Risk Assessment , By Country , 2015 – 2022 ( USD Million ) 
 Table 146 Europe : Market for Risk Assessment , By Country , 2015 – 2022 ( USD Million ) 
 Table 147 Asia Pacific : Market for Risk Assessment , By Country , 2015 – 2022 ( USD Million ) 
 Table 148 Global Market for Other Applications , By Region , 2015 – 2022 ( USD Million ) 
 Table 149 North America : Market for Other Applications , By Country , 2015 – 2022 ( USD Million ) 
 Table 150 Europe : Market for Other Applications , By Country , 2015 – 2022 ( USD Million ) 
 Table 151 Asia Pacific : Market for Other Applications , By Country , 2015 – 2022 ( USD Million ) 
 Table 152 Global Market , By Region , 2015 – 2022 ( USD Million ) 
 Table 153 North America : Market , By Country , 2015 – 2022 ( USD Million ) 
 Table 154 North America : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 156 North America : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 161 North America : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 162 US : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 163 US : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 164 US : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 169 US : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 170 Canada : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 171 Canada : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 172 Canada : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 177 Canada : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 179 Europe : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 180 Europe : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 181 Europe : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 186 Europe : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 187 Germany : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 188 Germany : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 189 Germany : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 194 Germany : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 195 UK : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 196 UK : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 202 UK : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 203 France : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 204 France : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 205 France : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 210 France : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 212 Italy : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 213 Italy : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 218 Italy : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 219 Spain : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 220 Spain : Market , By Biomarker Type , 2015 – 2022 ( USD Million ) 
 Table 221 Spain : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 226 Spain : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 228 RoE : Market , By Type , 2015 – 2022 ( USD Million ) 
 Table 229 RoE : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 234 RoE : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 236 Asia Pacific : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 237 Asia Pacific : Market , By Type , 2015 – 2022 ( USD Million ) 
 Table 238 Asia Pacific : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 243 Asia Pacific : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 245 Japan : Market , By Type , 2015 – 2022 ( USD Million ) 
 Table 246 Japan : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 251 Japan : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 252 Rest of APAC : Market , By Cancer Type , 2015 – 2022 ( USD Million ) 
 Table 253 Rest of APAC : Market , By Biomarker Type , 2015 – 2020 ( USD Million ) 
 Table 254 Rest of APAC : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 259 Rest of APAC : Market , By Application , 2015 – 2022 ( USD Million ) 
 Table 261 RoW : Market , By Type , 2015 – 2022 ( USD Million ) 
 Table 262 RoW : Market , By Profiling Technology , 2015 – 2022 ( USD Million ) 
 Table 267 RoW : Market , By Application , 2015 – 2022 ( USD Million ) 
 Figure 6 Cancer Biomarker Market , By Cancer Type , 2017 vs 2022 ( USD Million ) 
 Figure 7 Cancer Biomarker Market , By Biomarker Type , 2017 vs 2022 ( USD Million ) 
 Figure 8 Cancer Biomarker Market , By Application , 2017 vs 2022 ( USD Million ) 
 Figure 9 Cancer Biomarker Market , By Profiling Technology , 2017 vs 2022 ( USD Million ) 
 Figure 15 Global Market , By Cancer Type 
 Figure 16 Omics Technologies Will Continue to Dominate the Global Market in 2022 
 Figure 17 Diagnostics Application Segment to Dominate the Market in 2017 
 Figure 18 Market : Geographic Snapshot ( 2017 – 2022 ) 
 Title : Cancer Biomarkers Market by Type ( Protein Biomarker , Genetic Biomarker ) , Cancer Type ( Breast , Melanoma , Leukemia , Lung ) , Profiling Technology ( Omics , Imaging , Immunoassay , Bioinformatics ) , Application ( Diagnosis , Prognostics , R & D ) - Global Forecast to 2022 
 The global cancer biomarkers market is accounted for USD 10 . 31 billion in 2016 and is expected to grow at a CAGR of 12 . 2 % to USD 20 . 48 billion by 2022 during the forecast period . Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body . Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer . They can be found in the blood , stool , urine , tumor tissue , or other tissues or bodily fluids . They enhance cancer detection and facilitate high - speed noninvasive diagnosis using Genomics and proteomics . 
 Pharmaceutical and biotech companies are increasingly focusing on the use of biomarkers in their drug discovery and development process and have formed strategic alliances for sharing technology for biomarker applications in large - stage clinical trials are fueling the growth of this market . The base year considered for the study is 2016 , and the forecast has been provided for the period between 2017 and 2022 . 
 Selected Market Dynamics in Cancer Biomarkers Market 
 Over the last few years , fields , such as diagnostic imaging , immunoassays , omics technologies , and bioinformatics have witnessed significant technological advancements . Moreover , several companies operating in the diagnostic imaging market are focusing on developing technologically - advanced equipment that are more economical , provide better patient safety , and are easy to use . 
 Advancements in omics technologies enable faster acquisition of genomic , proteomic , and metabolomic data , and its integration with clinical trial data using advanced bioinformatics software . The omics revolution in the last decade has increased the applications of biomarkers in biomedical research . Also , developments in high - throughput genomic technologies are facilitating the identification and analysis of mutations and polymorphisms in key genes , thus expanding the spectrum of available genomic biomarkers . For instance , researchers at the Mayo Clinic have identified the role of mutations in the SPOP gene on the development of resistance to BET . With these advancements , the number of available genomic biomarkers for the detection of cancer is expected to increase . 
 Many epidemiology studies use biomarkers to investigate different stages of diseases in humans . This requires careful handling and storage of precious biological samples for obtaining a large amount of information from limited samples and minimizing future research costs through the use of banked samples . Sample collection is thus one of the key issues for service providers , followed by the access to these samples . A stringent quality control of these samples is required and they need to be stored under the right conditions to avoid any loss . Also , different samples are required for risk detection , screening , diagnosis , and monitoring processes . 
 The validity of results from biomarkers studies using archived specimens depends on the integrity of specimens and the manner in which they are collected , processed , and stored . Apart from the maintenance of samples , specimen banks have to be structured so that all elements of patient rights , privacy , and confidentiality are addressed with an informed consent that is thorough and addresses the potential use of samples . Furthermore , detailed tracking , specimen storage , and retrieval software are required for proper sample handling and management . These issues are expected to hinder the growth of the overall cancer biomarkers market . 
 Cancer biomarkers Market : Objectives of the Study 
 To define , describe , and segment the global market by type , cancer type , profiling technology , application , and region 
 To analyze micromarkets 1 with respect to individual growth trends , prospects , and contributions to the global market 
 To profile key players in the market and comprehensively analyze their market shares and core competencies 2 
 To track and analyze competitive developments such as acquisitions , product launches , expansions , and other developments in the cancer biomarkers market 
 Cancer biomarkers Market : Research Methodology 
 Top - down and bottom - up approaches were used to validate the size of the global Patient Lateral Transfer market and estimate the size of other dependent submarkets . Various secondary sources such as World Health Organization , World Bank , Centers for Disease Control and Prevention , National Institutes of Health , Canadian Institute of Health Information , National Cancer Institute , European Association for Cancer Research , Australian Cancer Research Foundation ( ACRF ) , GLOBOCAN 2012 , Cancer Journal for Clinicians , World Bank , U . S . Census Bureau , Canadian Institute of Health Information , databases , and annual reports of the companies have been used to identify and collect information useful for the study of this market . Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market . The breakdown of profiles of primaries is shown in the figure below : 
 The market is dominated by established players such as Thermo Fisher Scientific , Roche Diagnostics , Agilent Technologies , Illumina , Abbott Laboratories , Qiagen N . V . , Merck & Co . , Becton Dickinson and Company , and Hologic . 
 Cancer biomarkers Market : Target Audience : 
 Manufacturing companies of diagnostics kits and imaging instrument providers 
 Biomarkers assay and reagent manufacturers , vendors , and distributors 
 Cancer biomarkers Market : Scope of the Report 
 2017 - e – 2022 - p 
 This research report categorizes the cancer biomarker market on the basis of biomarker type , cancer type , profiling technology , application , and region . 
 Global Cancer Biomarker Market , By Type 
 Other Cancer Biomarkers ( cell , viral , and carbohydrate biomarkers ) 
 Global Cancer Biomarker Market , By Cancer Type 
 Other Cancers ( multiple myeloma , cervical , central nervous system cancer , gastric , liver , pancreatic , oral cavity and pharynx , stomach , and ovarian cancer 
 Global Cancer Biomarker Market , By Profiling Technology 
 Global Cancer Biomarker Market , By Application 
 Other Applications ( personalized medicine , surrogate endpoints , and therapeutics ) 
 Global Cancer Biomarker market , by Region 
 Company Information , detailed analysis and profiling of additional market players ( Up to 5 ) 
 The global cancer biomarker market is projected to reach USD 20 . 48 billion by 2022 from USD 11 . 53 billion in 2017 , at a CAGR of 12 . 2 % from 2017 to 2022 . 
 Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body . Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer . They can be found in the blood , stool , urine , tumor tissue , or other tissues or bodily fluids . They enhance cancer detection and facilitate high - speed noninvasive diagnosis using genomics and proteomics . 
 The cancer biomarkers market on the basis of cancer type is classified into breast , lung , colorectal , prostate , melanoma , leukemia , thyroid , bladder , non - hodgkin ’ s lymphoma , kidney , and other cancers . In 2017 , the breast cancer segment is expected to account for the largest share of the global market by cancer type . The largest share of this segment is mainly attributed to the high prevalence of breast cancer over the last few years , increased awareness about breast cancer diagnosis , and increasing research focus on breast cancer . 
 On the basis of application , the market is classified into diagnostics , research and development , prognostics , risk assessment , and other applications . In 2017 , the diagnostics segment is expected to account for largest share of the global cancer biomarkers market . The large share of this segment is mainly attributed to the rising incidences of cancer , increased awareness and acceptance of diagnostic tests , technological advancements , and the need for early - stage cancer diagnosis . 
 The Asia - Pacific region is expected to grow at the highest CAGR during the forecast period . While North America ( comprising the U . S . and Canada ) is expected to account for the largest share of the global cancer biomarker market in 2017 . The Asia - Pacific cancer biomarker market , particularly in China , Japan , and India is expected to witness high growth in the forecast period . Factors such as rising incidence of cancer , increasing use of biomarker tests for diagnostic purposes , expansions of major pharmaceutical companies in emerging Asian economies , and government support to research institutes and universities are further drive the growth of this market in the APAC region . 
 Rising adoption of genomics technologies in drug discovery and clinical applications such as NGS and PCR are driving the growth of cancer biomarker market . 
 Where will all these technologies take the industry in the mid to long term ? 
 What are the segments which offers lucrative opportunity in cancer biomarker market ? 
 Significant capital investments are required for the discovery , development , and validation of biomarkers . This is a major factor restraining the growth of the biomarkers market and other related markets such as diagnostics ( in vitro diagnostics or companion diagnostics ) and personalized medicine . The discovery of candidate biomarkers far outpaces the current ability to validate them . In addition , due to the high drug attrition in clinical trials ( with almost 30 % drugs failing in phase III ) , diagnostics manufacturers are facing significant financial challenges . To gain approval for an IVD from regulators , manufacturers need successful phase III clinical trials , which depend on well - validated biomarker tests . Huge investments are required to run clinical trials and address stringent regulatory requirements , which not only affects the ability of small companies to develop biomarkers but also severely affects innovation . 
 The cancer biomarkers market is dominated by established players such as Thermo Fisher Scientific , Roche Diagnostics , Agilent Technologies , Illumina , Abbott Laboratories , Qiagen N . V . , Merck & Co . , Becton Dickinson and Company , and Hologic .